CAH
Healthcare · Medical Distribution
Performance
CAH (CAH) Stock Analysis 2026
Rule-based · Updated daily · Not financial advice
CAH (CAH) operates in the Medical Distribution space within the Healthcare sector. With a market cap of $53.6B, it qualifies as a mid-cap company. Growth is moderate and the business remains profitable, offering a balanced risk/reward profile compared to high-multiple peers.
- Forward P/E (19.1×) is lower than trailing P/E (35.0×) — analysts expect earnings to improve
- Revenue growth of 11% YoY shows solid business momentum
- Low beta of 0.53 — less volatile than the market, suitable for conservative portfolios
- P/E of 35.0× is above average — valuation requires continued strong growth to justify
- Earnings fell 20% YoY — profitability is under pressure
- Thin profit margin of 0.6% — little buffer against cost increases
- Current ratio below 1 (0.91×) — short-term liabilities exceed current assets
- Price is near its 52-week high — limited near-term upside, higher pullback risk
Verdict
Avoid
Significant fundamental concerns outweigh positives. High risk at current levels.
AI Insight
Powered by ClaudeAI-generated analysis for informational purposes only. Not financial advice.
Related Articles
Revenue & Results
Dividends
Current DY
0.90%
5Y Avg Annual
$1.7094
Last Payment
$0.5110
Ex-Date
04/01/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest04/01/2026 | 04/15/2026 | $0.5110 | 0.89% |
01/02/2026 | 01/16/2026 | $0.5110 | 0.89% |
10/01/2025 | 10/15/2025 | $0.5110 | 0.89% |
07/01/2025 | 07/15/2025 | $0.5110 | 0.89% |
04/01/2025 | 04/15/2025 | $0.5060 | 0.89% |
01/02/2025 | 01/16/2025 | $0.5060 | 0.89% |
10/01/2024 | 10/15/2024 | $0.5060 | 0.89% |
07/01/2024 | 07/15/2024 | $0.5060 | 0.89% |
Magic Number
Shares needed to self-fund your next purchase
$228.68
Price
$0.5110
Last div. (quarterly)
448
shares
Own 448 CAH shares ($102,448.64) and each quarterly dividend pays for 1 new share — the snowball runs on its own.
Investment target
$102,448.64
New shares / year
+4 shares
If You Had Invested…
Hypothetical return based on historical prices
* Dividend reinvestment calculated at ex-date price. For informational purposes only.
Earnings
EPS (TTM)
$6.54
P/E (TTM)
35.0
Fwd P/E
19.1
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Key Statistics
Valuation
Trading
Dividends
Profitability
Balance Sheet
Fair Value Estimates
Current price: $228.68
Graham Number
√(22.5 × EPS × Book Value)
N/A
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$31.61
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
6/10
75% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
Return on equity — measures how efficiently capital is used
Positive profit margin
0.6%Net profit margin must be positive — company earns more than it spends
Revenue growth (annual)
+11.0%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
-19.5%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
Low financial leverage reduces risk of distress
Current ratio above 1
0.91×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$476M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
0.90%Stock must distribute income to shareholders
Related Assets
Healthcare
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Sector
Healthcare
Industry
Medical Distribution
Location
Dublin, United States
Employees
53,084